Literature DB >> 31663978

An Analysis of User Survey Data for an Internet Program for Testing for Sexually Transmitted Infections, I Want the Kit, in Maryland and Washington, DC.

Eiluned Hogenson1, Mary Jett-Goheen2, Charlotte A Gaydos2.   

Abstract

We evaluated the results of an acceptability survey administered online to users of I Want the Kit, which offers Internet-requested kits for sexually transmitted infection screening. User satisfaction was high for I Want the Kit, with many users in our survey being repeat patients of this program. Both male and female respondents preferred genital self-collected swabs over urine collected specimens. Strong interest was expressed in home testing options for other sexually transmitted infections.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31663978      PMCID： PMC6878174          DOI： 10.1097/OLQ.0000000000001061

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


  4 in total

1.  US Public Sexually Transmitted Disease Clinical Services in an Era of Declining Public Health Funding: 2013-14.

Authors:  Jami S Leichliter; Kate Heyer; Thomas A Peterman; Melissa A Habel; Kathryn A Brookmeyer; Stephanie S Arnold Pang; Mark R Stenger; Gretchen Weiss; Thomas L Gift
Journal:  Sex Transm Dis       Date:  2017-08       Impact factor: 2.830

2.  Cost-effectiveness analysis of Chlamydia trachomatis screening via internet-based self-collected swabs compared with clinic-based sample collection.

Authors:  Wei Huang; Charlotte A Gaydos; Mathilda R Barnes; Mary Jett-Goheen; Diane R Blake
Journal:  Sex Transm Dis       Date:  2011-09       Impact factor: 2.830

3.  Internet-based screening for Chlamydia trachomatis to reach non-clinic populations with mailed self-administered vaginal swabs.

Authors:  Charlotte A Gaydos; Karen Dwyer; Mathilda Barnes; Patricia A Rizzo-Price; Billie Jo Wood; Toni Flemming; M Terry Hogan
Journal:  Sex Transm Dis       Date:  2006-07       Impact factor: 2.830

4.  Point-of-care tests for sexually transmissible infections: what do 'end users' want?

Authors:  Anne M Rompalo; Yu-Hsiang Hsieh; Terry Hogan; Mathilda Barnes; Mary Jett-Goheen; Jill S Huppert; Charlotte A Gaydos
Journal:  Sex Health       Date:  2013-12       Impact factor: 2.706
  4 in total
  6 in total

Review 1.  Diagnostic Tests for Detecting Chlamydia trachomatis and Neisseria gonorrhoeae in Rectal and Pharyngeal Specimens.

Authors:  Paul C Adamson; Jeffrey D Klausner
Journal:  J Clin Microbiol       Date:  2021-11-03       Impact factor: 11.677

2.  Contraception in Person-Contraception Online (CiP-CO) cohort study.

Authors:  Emma Rezel-Potts; Melissa J Palmer; Caroline J Free; Hannah McCulloch; Paula Baraitser
Journal:  BMJ Sex Reprod Health       Date:  2021-08-27

3.  Scaling Up CareKit: Lessons Learned from Expansion of a Centralized Home HIV and Sexually Transmitted Infection Testing Program.

Authors:  Jenna Norelli; Maria Zlotorzynska; Travis Sanchez; Patrick S Sullivan
Journal:  Sex Transm Dis       Date:  2021-08-01       Impact factor: 3.868

4.  At-Home Testing for Sexually Transmitted Infections During the COVID-19 Pandemic.

Authors:  Caroline Carnevale; Paul Richards; Renee Cohall; Joshua Choe; Jenna Zitaner; Natalie Hall; Alwyn Cohall; Susan Whittier; Daniel A Green; Magdalena E Sobieszczyk; Peter Gordon; Jason Zucker
Journal:  Sex Transm Dis       Date:  2021-01       Impact factor: 3.868

5.  Impact of the COVID-19 Pandemic on Chlamydia and Gonorrhea Tests Performed by a Large National Laboratory-United States, 2019 to 2020.

Authors:  Guoyu Tao; Stephanie Dietz; Kathleen P Hartnett; Praveena Jayanthi; Thomas L Gift
Journal:  Sex Transm Dis       Date:  2022-04-23       Impact factor: 3.868

6.  How do users of a 'digital-only' contraceptive service provide biometric measurements and what does this teach us about safe and effective online care? A qualitative interview study.

Authors:  Paula Baraitser; Hannah McCulloch; Alessandra Morelli; Caroline Free
Journal:  BMJ Open       Date:  2020-09-29       Impact factor: 2.692
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.